Zytrip Tablets

Zytrip Tablets

S5
PDF Leaflet Revision Date: 06 December 2022


Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of endogenous depression and nocturnal enuresis in children over 6 years.

Dosage (summary)

Depression: 25 mg three times daily, up to 150 mg; Nocturnal enuresis: 10-50 mg at bedtime for children.

Onset of Action / Duration

Onset: 3-4 days, Duration: up to 30 days for full effect.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Not recommended during pregnancy or breastfeeding due to potential risks.

Key Drug Interactions

  • MAOIs
  • CNS depressants
  • Antihypertensives

Contraindications

  • Hypersensitivity
  • Acute myocardial infarction
  • Heart block
  • Severe liver disease

Common side effects

  • Dry mouth
  • Constipation
  • Drowsiness
  • Tachycardia

Counselling Points

  • Avoid alcohol
  • Do not drive until effects are known
  • Monitor for suicidal thoughts

Serious warnings

  • Risk of suicidal thoughts
  • Cardiac dysrhythmias
  • Severe anticholinergic effects
Important Disclaimer

The Zytrip Tablets professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites